HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest Articles

Global Policy, Regulation & Law

Refillable Personal-Care Packaging: Experts Discuss Contamination Risks, Liability, MoCRA Compliance

Personal-care companies navigating a growing patchwork of state recycling laws are exploring refillable packaging options, but there are serious concerns and questions to consider before embarking down this potentially risky path, experts said at IBA’s Supply Chain & Sustainability Conference.

NPA Complaint For Preemption Argues New York Swings Wildly With Age-Restricted Sales Law

New York law crosses so many federal regulations it would also affect Rx drug sales while allowing consumers to file complaints alleging businesses violate the law, NPA argues in complaint filed in federal court in New York City.

Will Constitution Stop New York's Diet Pill Sales Rule Despite State Age-Restricting DXM OTCs?

NPA argues in complaint that limiting purchases of weight loss and bodybuilding OTC drugs and supplements to consumers 18 and older preempted not only by FD&C Act regulations but also by Commerce Clause of the US Constitution.

French Regulator At Odds With EMA Over Safety Restrictions For Pseudoephedrine

The product information for all pseudoephedrine-containing medicines in the EU will need to be updated, the European Medicines Agency said.

Digital Health & AI

NPA Complaint For Preemption Argues New York Swings Wildly With Age-Restricted Sales Law

New York law crosses so many federal regulations it would also affect Rx drug sales while allowing consumers to file complaints alleging businesses violate the law, NPA argues in complaint filed in federal court in New York City.

Will Constitution Stop New York's Diet Pill Sales Rule Despite State Age-Restricting DXM OTCs?

NPA argues in complaint that limiting purchases of weight loss and bodybuilding OTC drugs and supplements to consumers 18 and older preempted not only by FD&C Act regulations but also by Commerce Clause of the US Constitution.

Bayer Extends Personalized Health Offering With At-Home Biological Age Test

Advancing personalized consumer innovation in healthy aging is the goal of a new partnership between Bayer and biological age test development firm Hurdle.

After At-Home Diagnostics Got Boost From COVID, FTC Shows False Claims Didn’t End With Pandemic

FTC and California Attorney General offer CRI Genetics LLC as exhibit A for making good on promised deliverables for DNA-based ancestry and information reports.

See All
Sustainability

Refillable Personal-Care Packaging: Experts Discuss Contamination Risks, Liability, MoCRA Compliance

Personal-care companies navigating a growing patchwork of state recycling laws are exploring refillable packaging options, but there are serious concerns and questions to consider before embarking down this potentially risky path, experts said at IBA’s Supply Chain & Sustainability Conference.

US State Laws To Address Packaging Waste Are Cosmetics Industry’s Newest Patchwork Problem

Beauty and personal-care companies building a compliance strategy across states should consider starting with California’s SB-54, as it is the “strictest law in place,” experts agreed at the Independent Beauty Association’s recent Supply Chain & Sustainability Conference. They encouraged companies to assess packaging across SKUs and participate in state-level regulatory development processes.

The Replacements: Cosmetic Ingredient Suppliers At Ready With Microplastic Alternatives As EU Ban Unfolds

HBW Insight reached out to suppliers of microplastic alternatives for cosmetics use to discuss their offerings and preparedness for demand surges under phased REACH prohibitions.

Beauty Supply Chain Hampered By ‘Post-COVID Hangover,’ Geopolitical, Climate Change Impacts

The global beauty ingredient supply chain is functioning again after pandemic-related lockdowns and other disruptions, but companies are having to contend with regional challenges, geopolitical turmoil and the impacts of climate change, supply and distribution experts said at the IBA Supply Chain and Sustainability Summit.

See All
Interviews

Get To Know: ‘Medicine Cabinet Staples’ Manufacturer Kobayashi Healthcare Europe

Manufacturing best-selling items like Kool 'n' Soothe cooling sheet, Cura-Heat heat pack and Hothands hand warmer brands in its own facilities means Kobayashi Healthcare Europe can offer “great quality products without breaking the bank,” explains marketing and regulatory manager Richard Noal.

Over The Counter 13 Nov 2023: How OTC Companies Can Respond To Preventative Health Trends, With Simon-Kucher & Partners

In this episode, HBW Insight speaks to Simon-Kucher & Partners about the latest trends in preventative consumer health. Partner Christian Rebholz and senior director Lorenzo Eandi explain the findings from the company’s recently published Better Health Report, which reached out to almost 3,000 consumers across the world. We take a deeper dive into Brazil, where consumers are spending more on than average on preventative health, and Germany, where consumers are spending less but are turning to digital tools thanks to government support. We also find out what consumer health companies can do to respond to a growing awareness of mental health, especially among women and the younger generation.

Female Sexual Dysfunction, China, Next On The Agenda For Eroxon Creator Futura

Drug-free erectile dysfunction “stimgel” creator Futura wants to see if the technology underpinning Eroxon can be applied to female sexual dysfunction. Breaking into China is also high up on the agenda for the UK-based R&D company's CEO James Barder, he reveals in this exclusive interview.

Can Digital Twin Technology Help Beat Chronic Disease? Twin Health Is Getting Users Hooked, And Off Their Meds

Twin Health’s Whole Body Digital Twin uses AI and patient data from sensors to help people with metabolic disease overcome their disease. The tech showed promise in a clinical trial of type 2 diabetes patients.

See All
Recent Stories

Refillable Personal-Care Packaging: Experts Discuss Contamination Risks, Liability, MoCRA Compliance

Personal-care companies navigating a growing patchwork of state recycling laws are exploring refillable packaging options, but there are serious concerns and questions to consider before embarking down this potentially risky path, experts said at IBA’s Supply Chain & Sustainability Conference.

NPA Complaint For Preemption Argues New York Swings Wildly With Age-Restricted Sales Law

New York law crosses so many federal regulations it would also affect Rx drug sales while allowing consumers to file complaints alleging businesses violate the law, NPA argues in complaint filed in federal court in New York City.

Will Constitution Stop New York's Diet Pill Sales Rule Despite State Age-Restricting DXM OTCs?

NPA argues in complaint that limiting purchases of weight loss and bodybuilding OTC drugs and supplements to consumers 18 and older preempted not only by FD&C Act regulations but also by Commerce Clause of the US Constitution.

Bayer Extends Personalized Health Offering With At-Home Biological Age Test

Advancing personalized consumer innovation in healthy aging is the goal of a new partnership between Bayer and biological age test development firm Hurdle.

Ulta Beauty Leadership Offers 2023 Holiday Outlook, AI Update In Q3 Earnings Call

The US’ biggest beauty retailer is targeting fiscal 2023 net sales between $11.1bn and $11.15bn, with comparable sales growth of 5% to 5.5%, and is optimistic about 2024 and longer-term strategies. CEO David Kimbell addressed analyst questions on the 2023 holiday season, AI and other points of interest during the firm’s third-quarter earnings call.

Pharmavite Sitting Out Trendy Spin-Off Dance

"Otsuka is very, very committed to nutraceuticals generally, and supplements specifically,” says Pharmavite CEO Jeff Boutelle.

Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line

“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.

French Regulator At Odds With EMA Over Safety Restrictions For Pseudoephedrine

The product information for all pseudoephedrine-containing medicines in the EU will need to be updated, the European Medicines Agency said.

Get To Know: ‘Medicine Cabinet Staples’ Manufacturer Kobayashi Healthcare Europe

Manufacturing best-selling items like Kool 'n' Soothe cooling sheet, Cura-Heat heat pack and Hothands hand warmer brands in its own facilities means Kobayashi Healthcare Europe can offer “great quality products without breaking the bank,” explains marketing and regulatory manager Richard Noal.

FDA’s Bumpus Will Be Principal Deputy Commissioner; Cosmetics Industry Reacts With Congratulations, Questions

Chief scientist Namandjé Bumpus will replace Janet Woodcock as principal deputy commissioner at the US FDA when the latter steps down in early 2024. The Personal Care Products Council says Bumpus will continue to lead MoCRA implementation efforts while a new chief scientist is sought, but those and other details remain fuzzy.

EU High Court Is ‘Indifferent To Modern Values’; Reactions To Cosmetic Ingredient Animal-Testing Decision

The Cosmetic Products Regulation’s “once groundbreaking” ban is now worthless, says PETA, which supported Symrise in two cases challenging animal testing required by the European Chemicals Agency for cosmetics-only ingredients under REACH. Cruelty Free Europe, the European Federation for Cosmetic Ingredients, and Unilever also intervened on Symrise’s behalf.

Democrat, Republican Pioneer Women In US House Won’t Return After 2024 Elections

Granger’s exit means House Appropriations will have different chair no matter which party wins majority 2024 elections; Democrats will lose senior House Energy and Commerce Health Subcommittee member with Eshoo’s retirement.

UsernamePublicRestriction

Register